RecruitingRecruiting
WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
NCT07558265 · Ohio State University
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
About this study
Acute hypoxemic respiratory failure (AHRF) is a serious medical emergency that frequently presents in the emergency department (ED) and requires immediate respiratory support to prevent further clinical deterioration. Patients with AHRF are at high risk for progression to invasive mechanical ventilation and death, and early management decisions may substantially influence outcomes.
Non-invasive respiratory support (NIRS) is widely used as first-line therapy for AHRF. Two commonly used NIRS strategies are non-invasive positive-pressure ventilation (NIPPV) and high-flow nasal oxygen (HFNO). Both modalities are accepted standards of care; however, their relative effectiveness and safety when applied early in the ED remain uncertain. Prior comparative studies have largely been conducted in intensive care settings, enrolled selected patient populations, or focused on single outcomes such as intubation or mortality. Consequently, equipoise persists regarding the optimal initial NIRS strategy for ED patients with undifferentiated AHRF.
The WINDSURFER trial (WIN ratio analysis to Determine a strategy of non-invasive SUpport for Respiratory Failure in the EmeRgency Department) is designed to compare two strategies of non-invasive respiratory support-NIPPV and HFNO-with respect to clinically meaningful outcomes in adult ED patients with acute hypoxemic respiratory failure.
The trial is conducted at multiple hospitals participating in the NIH funded Strategies to Innovate Emergency Care Clinical Trials Network (SIREN), enabling enrollment across diverse emergency care environments.
The study enrolls adult patients early in their ED course, reflecting the population in which initial respiratory support decisions are most consequential.
Participants are randomly assigned in equal proportions to one of the two study strategies, with allocation managed centrally through a secure electronic system to ensure balance across sites.
The assigned strategy is implemented as the initial approach to non invasive respiratory support for a defined protocolized period, after which ongoing respiratory management is determined by the treating clinical team according to standard clinical practice.
Clinical data are collected from the medical record and study specific assessments to characterize baseline features, treatment course, and in hospital events. Follow up extends through hospitalization and a defined post randomization observation period to ensure complete capture of relevant clinical outcomes.
Ethical Considerations: Because AHRF is a life-threatening emergency requiring immediate intervention and patients frequently lack decision making capacity at presentation, the study is conducted under Exception From Informed Consent (EFIC) in accordance with Food and Drug Administration (FDA) regulations (21 CFR 50.24). Community consultation and public disclosure are completed prior to enrollment at each site. Participants or their Legally Authorized Representatives are informed of enrollment at the earliest feasible opportunity and may withdraw from the study at any time.
Eligibility criteria
Inclusion Criteria:
* Age ≥18 years
* Presenting to the Emergency Department (ED) with Acute Hypoxemic Respiratory failure (AHRF), defined as:
* \[(respiratory rate ≥25 breaths/min) AND (requiring ≥6 L/min of oxygen required to maintain SpO2 ≥90%), OR SpO2:FiO2 ratio\<250\] OR
* Arrival at ED on prehospital Non-Invasive Respiratory Support (NIRS).
* Clinical need for NIRS
* Randomization ≤2 hours after identification of need for NIRS
* Randomization ≤6 hours of ED arrival
Exclusion Criteria:
* Urgent need for intubation
* Cardiac arrest
* Respiratory arrest
* Patient not located in the ED
* Craniofacial anatomic features that prohibit either Non-Invasive Positive Pressure Ventilation (NIPPV) or High Flow Nasal Oxygen (HFNO) interface
* Tracheostomy or laryngectomy stoma
* Hemodynamic instability requiring \>0.2mcg/kg/min of norepinepherine (or equivalent) to maintain mean arterial pressure \>65mmHg
* Pre-existing "do not resuscitate" or "do not intubate" order
* Home use of non-invasive positive-pressure ventilation for respiratory support of a medical condition other than sleep apnea
* Transferred from another Emergency Department
* History of advanced chronic obstructive pulmonary disease
* History of advanced heart failure
* Presence of opt-out identification
* Prisoner
* Known or apparent pregnant
* Previous enrollment in WINDSURFER
* A patient-specific contraindication makes one assigned study intervention unsafe
Study design
Enrollment target: 500 participants
Allocation: randomized
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2026-08-18
Estimated completion: 2031-08
Last updated: 2026-11-05
Interventions
Device: Non-Invasive Positive Pressure VentilationDevice: High Flow Nasal Oxygen
Primary outcomes
- • Number of Subjects with Major Adverse Pulmonary Event (MAPE) (a) Hospital Death up to 28 days after randomization b) Maximum of 28 ventilator days c) Maximum of 24 NIRS hours)
Sponsor
Ohio State University · other
With: National Heart, Lung, and Blood Institute (NHLBI), University of Michigan, Medical University of South Carolina, University of Arizona, Baystate Medical Center
Contacts & investigators
ContactHenry E Wang, MD, MS · contact · Henry.wang@osumc.edu · 614-648-1372
ContactValerie L Durkalski-Mauldin, PhD · contact · durkalsv@musc.edu · 843-876-1911
InvestigatorHenry E Wang, MD, MS · principal_investigator, Ohio State University
InvestigatorJarrod Mosier, MD · principal_investigator, University of Arizona
InvestigatorMark Tidswell, MD · principal_investigator, Baystate Health
All locations (9)
Banner University Medical Center TucsonRecruiting
Tucson, Arizona, United States
Yale New Haven HospitalRecruiting
New Haven, Connecticut, United States
University of Michigan Medical CenterRecruiting
Ann Arbor, Michigan, United States
Wake Forest Baptist Medical CenterRecruiting
Winston-Salem, North Carolina, United States
Ohio State East HospitalRecruiting
Columbus, Ohio, United States
OSU Wexner Medical CenterRecruiting
Columbus, Ohio, United States
Temple University HospitalRecruiting
Philadelphia, Pennsylvania, United States
Intermountain Medical CenterRecruiting
Murray, Utah, United States
Harborview Medical CenterRecruiting
Seattle, Washington, United States